← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neuroene Therapeutics Inc
Washington, DC
$2,384,262
Total funding
3
Grants
Funding over time
peak $811.5K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,384,262 · 3
By mechanism
R44$1,561,448 · 1
R43$598,010 · 1
R41$224,804 · 1
Investigators at Neuroene Therapeutics Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of new anti-epilepsy treatments targeting cellular energetics through mitochondrial modulation with optimal pharmacokinetics and toxicity profiles$749,959
R44 · FY2018 · NS
Development of new anti-epilepsy treatments targeting cellular energetics through mitochondrial modulation with optimal pharmacokinetics and toxicity profiles$749,959
R44 · FY2019 · NS
A Vitamin K analog countermeasure for organophosphate poisoning$299,713
R43 · FY2024 · AI
A Vitamin K analog countermeasure for organophosphate poisoning$298,297
R43 · FY2023 · AI
Novel mechanism for the treatment of epilepsy: New Vitamin K analogs target energetics and have low toxicity due to excellent specificity and low dose requirements compared to current therapies$224,804
R41 · FY2016 · NS
Administrative Supplement to Promote Diversity in Research and Development Small Businesses$61,530
R44 · FY2019 · NS